02-May-2016 - As a significant amount of drug discoveries occur outside of pharma companies, Elsevier has launched The Hive Project to promote innovation in the market – outside its walls.
26-Apr-2016 - Worldwide Clinical Trials (WCT) has opened a clinical trial material storage depot in St Petersburg, Russia citing increasing customer demand.
25-Apr-2016 - The WHO has accused Semler Research of data fraud and said Mylan, Micro Labs, Lupin and Strides and others may need to repeat bioanalytical trials conducted by the CRO.
21-Apr-2016 - Exco InTouch has formed a strategic partnership with Regulatory Strategies, a data protection and compliance consultancy, in response to upcoming reforms.
20-Apr-2016 - BioClinica and ArisGlobal have partnered to offer customers a comprehensive pharmacovigilance service as "one size fits all" model evolves.
19-Apr-2016 - Heptares Therapeutics and Kymab Limited have entered into a strategic collaboration to discover, develop, and commercialize novel antibody therapeutics.
14-Apr-2016 - Using an experimental Internet of Things system that enables remote monitoring, the companies believe the multi-year project has the potential to change the way clinical trials are conducted.
13-Apr-2016 - Sekisui XenoTech announced that it now offers genotyped hepatocytes for polymorphic enzyme drug metabolism studies as part of its cell- and tissue-based product catalog.
13-Apr-2016 - The new company, JW Biotechnology, will draw on Juno’s immuno-oncology expertise and WuXi AppTec’s R&D and manufacturing platform.
07-Apr-2016 - Heat Biologics has announced several "necessary" but "incredibly difficult" cost cutting measures, including a workforce reduction of approximately 22%.
06-Apr-2016 - US CRO inVentiv Health has signaled its intention to go public by filing an S1 with the Securities and Exchange Commission (SEC) last night.
23-Mar-2016 - Evotec has attributed strong growth in 2015 to its deal with Sanofi and says it will continue to pursue such strategic partnerships.
17-Mar-2016 - Eurotrials has opened an office in Mexico City in a bid the dominant CRO in the growing Mexican clinical research market.
16-Mar-2016 - The drug industry needs to rethink what defines a ‘high-risk’ candidate say an expert calling for more detailed pharmacological studies in the wake of the BIA 10-2474 tragedy.
08-Mar-2016 - Exco InTouch has partnered with Oracle Health Sciences to develop an integrated EDC/ePRO system for clinical trials.
07-Mar-2016 - One-third of clinical-trials results in the US go unreported, according to new figures published in the British Medical Journal underlining how far the drugs industry remains from full transparency.
07-Mar-2016 - Drugmakers seeking to stop “commercially confidential information” being made public in trial reports will need to demonstrate the likely economic harm publishing it would cause says the EMA.
07-Mar-2016 - Synexus has bought trial site network Research Across America (RAA) in a deal it claims will give its customers access to the US market and additional study participants.
03-Mar-2016 - Medpace will run a Phase III trial of candidate blood cancer treatment Iomab-B under a new contract with developer Actinium Pharmaceuticals.
01-Mar-2016 - The drug pricing debate continues as Hillary Clinton releases a new campaign video attacking Valeant - but how did we get here?
01-Mar-2016 - Genentech, a member of the Roche Group, has announced top-line results from two phase III studies, which had conflicting results.
25-Feb-2016 - Heat Biologics will no longer enrol patients in the arm of a Phase II trial examining its cell therapy HS-410 (vesigenurtacel-L) as a monotherapy for bladder cancer.
24-Feb-2016 - Recipharm will pay SEK640m ($75m) for Italian antibiotic filling specialist Mitim in a deal expected to complete later today.
24-Feb-2016 - Unchained Labs has acquired Freeslate, a provider of high-throughput solutions for biologics formulation development and small molecule chemistry – marking the company’s 4th acquisition in 12 months.
17-Feb-2016 - Parexel has set up a team of ex-GSK genomics experts in response to growing sponsor demand for “precision medicine” development knowhow.